Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |